BioMicro to exploit Myriad's microfluidic method:
This article was originally published in Clinica
Myriad Genetics (Salt Lake City, Utah) has been awarded a US patent for its microfluidic passive fluid dynamics technology and has licensed the patent rights to BioMicro Systems. Unlike conventional active systems that require sound, electricity or mechanical valves to control the movement of fluid, passive fluid control devices use constrictions in the microchannels to regulate the flow of liquids in microfluidic devices. BioMicro says the technology can be used to develop diagnostic products as well as products for use in genomic and drug discovery research.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.